McKesson Corporation is a leading healthcare services and information technology company that specializes in the distribution of pharmaceuticals and medical supplies. The company provides a comprehensive range of services that enhance the efficiency of healthcare systems, including drug distribution to pharmacies, hospitals, and other healthcare providers. Additionally, McKesson offers innovative solutions for managing medical costs, optimizing inventory, and improving patient care through data analytics and technology. By ensuring the timely delivery of critical medical products and services, McKesson plays a vital role in the healthcare ecosystem, supporting both providers and patients. Read More
Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 6% year on year ...
McKesson Corporation (NYSE: MCK) has released its fiscal 2026 fourth quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Healthcare distributor and services company McKesson (NYSE:MCK) will be reporting earnings this Thursday afternoon. Here’s what investors should know. McKess...
McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, today announced it has entered into a definitive agreement with funds managed by affiliates of Apollo (“Apollo Funds”), under which Apollo Funds will acquire a minority ownership interest in McKesson’s Medical-Surgical Solutions (“MMS”) business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public offering.
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & services industry, including McKesson ...
In the complex, high-stakes machinery of the American healthcare system, few companies are as indispensable—yet as quietly influential—as McKesson Corporation (NYSE: MCK). As of March 18, 2026, McKesson stands not merely as a distributor of pills and medical supplies, but as a sophisticated healthcare services platform that has successfully pivoted from low-margin logistics to high-value [...]
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
McKesson Corporation (NYSE: MCK) today announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful and distinguished 20-year career with the company, including more than eight years as CFO. Looking ahead, Kenny Cheung will join McKesson as Executive Vice President and CFO, effective May 29, 2026.
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
What a fantastic six months it’s been for McKesson. Shares of the company have skyrocketed 42.9%, setting a new 52-week high of $988.29. This performance may have investors wondering how to approach the situation.
The latest data from the U.S. Census Bureau, released in late February 2026, suggests a surprising degree of resilience within the American supply chain. Wholesale inventories for December 2025 rose by a modest 0.2%, reaching a total of $918.0 billion. This figure, which aligns perfectly with analyst
